Peixoto de Miranda EJF, Calado RT, Boulos FC, de Sousa Moreira JA, et al. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil. Vaccine 2025;52:126680.
PMID: 40037239